Alliqua BioMedical Inc (ALQA)

0.36
NASDAQ : Health Care
Prev Close 0.36
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.32 / 1.29
Avg Volume 305.80K
Exchange NASDAQ
Shares Outstanding 45.98M
Market Cap 16.09M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Alliqua BioMedical, Inc. Reports First Quarter Of Fiscal Year 2017 Financial Results

Q1'17 Product revenue from continuing operations increased 28% year-over-year, led by Biologics growth of 197% year-over-year

Alliqua BioMedical, Inc. Announces Preliminary First Quarter Fiscal 2017 Revenue And Updates Fiscal Year 2017 Outlook; Earnings Conference Call Scheduled For May 9, 2017

Preliminary Q1'17 product sales increase 28% year-over-year led by biologics growth of approximately 200% year-over-year

Alliqua BioMedical, Inc. To Present New Data At The Spring 2017 Symposium On Advanced Wound Care

Features Five New Poster Presentations on Interfyl™ and UltraMIST® Therapy

Alliqua BioMedical, Inc. Reports Fourth Quarter And Fiscal Year 2016 Financial Results

FY'16 Product revenue from continuing operations increased 60% year-over-year, led by Biologics growth in excess of 115% year-over-year

Alliqua BioMedical, Inc. Reports Third Quarter And Nine-Months Fiscal Year 2016 Financial Results

Alliqua BioMedical, Inc. Reports Third Quarter And Nine-Months Fiscal Year 2016 Financial Results

Third Quarter Product Revenue Growth of 18% year-over-year

Alliqua BioMedical, Inc. Announces Expansion Of Medicare Reimbursement Coverage For MIST Therapy®

Alliqua BioMedical, Inc. Announces Expansion Of Medicare Reimbursement Coverage For MIST Therapy®

Medicare Coverage for MIST Therapy® Now Includes All Medicare Administrative Contractors

Alliqua BioMedical, Inc. To Acquire Soluble Systems, LLC

Alliqua BioMedical, Inc. To Acquire Soluble Systems, LLC

Transaction Further Establishes Alliqua BioMedical as a Leading Provider of Regenerative Technologies

Alliqua BioMedical, Inc. Reports Second Quarter And Six Months Fiscal Year 2016 Financial Results

Alliqua BioMedical, Inc. Reports Second Quarter And Six Months Fiscal Year 2016 Financial Results

Revenue Growth from Continuing Operations of 80% year-over-year; Gross Margin Increases to 64%

These 5 Stocks Are Primed for Breakouts

These 5 Stocks Are Primed for Breakouts

Here's a technical look at how to trade five stocks triggering breakout trades.

6 Stocks Under $10 Making Big Moves Higher

6 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering breakout trades.

6 Stocks Under $10 Making Big Moves Higher

6 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Alliqua BioMedical, Inc. Reports First Quarter Financial Results

Alliqua BioMedical, Inc. Reports First Quarter Financial Results

Revenue Growth of 120% year-over-year; Reaffirms Fiscal Year 2016 Guidance

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering breakout trades.